Skip to main content
INNOGENE Co., Ltd. logo

INNOGENE Co., Ltd. — Investor Relations & Filings

Ticker · 344860 ISIN · KR7344860002 KO Manufacturing
Open in API
Filings indexed 144 across all filing types
Latest filing 2022-03-21 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 344860

About INNOGENE Co., Ltd.

http://eng.innogene.com

INNOGENE Co., Ltd. is a company specializing in anti-aging solutions. It develops, manufactures, and distributes advanced therapeutic products and cosmetics focused on skin regeneration and hair follicle health. The company's research and development leverages core technologies in medical informatics and a stem cell database to create its product portfolio. These solutions are designed to address concerns related to skin aging and hair loss, based on scientific studies of stem cell applications and healthy beauty.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Interim / Quarterly Report Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'InnoGene' (주식회사 이노진) for the fiscal year 2021. It includes the independent auditor's report, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. This is a comprehensive annual financial report, not an announcement or a summary, and it contains full financial data. FY 2021
2022-03-21 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for the company 'Innogene'. It contains the date, location, agenda items (financial statement approval, board appointments, stock split), and management reference materials (business overview, industry analysis). This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and provide necessary information for voting. In the provided classification schema, this fits best under 'Proxy Solicitation & Information Statement'.
2022-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company 'InnoGen'. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and stock splits), and provides background information on the nominees. This document is a standard proxy solicitation material sent to shareholders to inform them of the meeting and request their participation/votes, which fits the definition of a Proxy Solicitation & Information Statement.
2022-02-24 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure period for the purpose of an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or voting results, but rather serves as a formal regulatory notification of the administrative process for the meeting. Given it is a standard regulatory announcement that does not fit into specific categories like DVA or AGM-R, it is classified as a general regulatory filing.
2021-12-14 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement (under 1,000 characters) confirming that an Investor Relations (IR) event took place on 2021-10-26. It provides details about the event, such as the location (website/YouTube) and the participants, and notes that the presentation materials are available on the Korea Exchange website. Since it is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the category of a regulatory filing announcement.
2021-10-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (acquisitions), and the purpose of holding (management influence) by a major shareholder (Kwon Deuk-moon) in the company 'InnoGene'. This falls under the category of Major Shareholding Notification.
2021-09-01 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.